BioCentury
ARTICLE | Clinical News

ARGX-111: Phase Ib started

September 23, 2013 7:00 AM UTC

arGEN-X began a dose-escalation, Belgian Phase Ib trial to evaluate ARGX-111 in about 35 patients whose tumors overexpress c-Met. The dose-escalation portion will be followed by a safety cohort expans...